Major, A., Ma, E., Masaquel, A., Tsang, M., Di, M., Kaur, S., Pophali, P., Werner, S., Bungay, R., Latremouille-Viau, D., Guerin, A., Reyes, C., Wu, M., Cassoli, L., Torka, P. (2025). Differences in patient-reported time toxicity between bispecific antibody (BsAb) options: Impact of treatment duration and dosing frequency on patient-reported time burden in relapsed/refractory (R/R) follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL). Blood. https://doi.org/10.1182/blood-2025-6181